VARIAR Study: Assessment of Short-term Efficacy and Safety of Rituximab Compared to an Tumor Necrosis Factor Alpha Antagonists as Second-line Drug Therapy in Patients With Rheumatoid Arthritis Refractory to a First Tumor Necrosis Factor Alpha Antagonist
Titel:
VARIAR Study: Assessment of Short-term Efficacy and Safety of Rituximab Compared to an Tumor Necrosis Factor Alpha Antagonists as Second-line Drug Therapy in Patients With Rheumatoid Arthritis Refractory to a First Tumor Necrosis Factor Alpha Antagonist
Auteur:
Torrente-Segarra, Vicenç Acosta Pereira, Asunción Morla, Rosa Ruiz, José Miguel Clavaguera, Teresa Figuls, Ramon Corominas, Hector Geli, Carme Roselló, Rosa de Agustín, Juan José Alegre, Cayetano Pérez, Carolina García, Angel Rodríguez de la Serna, Arturo
Verschenen in:
Reumatologia clinica (English edition)
Paginering:
Jaargang 12 (2016) nr. 6 pagina's 4 p.
Jaar:
2016
Inhoud:
Uitgever:
Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología